Abbott Laboratories
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$110.16+3.96 (+3.73%)
Close on Nov 2, 2026Market cap $190.62BP/E 35.4Yield 2.18%
Abbott Laboratories Total U.S. — Annual Volume Growth by Year
Total U.S. — Annual Volume Growth (%) (%)
Abbott Laboratories Total U.S. — Annual Volume Growth: 4.9% in FY2025, up 1.2 pts from a year earlier.
Latest, FY2025
4.9%
Period ended Dec 31, 2025
Change on a year earlier
+1.2 pts
3.7% in FY2024
History
14 years
Since FY2012
Sources
13
Documents cited below
Where the FY2025 figure comes from
“|| Components of % Change || Total % Change | Price | Volume | Exchange || Total Net Sales || 2025 vs. 2024 | 5.7 | 0.7 | 4.8 | 0.2 || TotalUS || 2025 vs. 2024 | 4.9 | — | 4.9 | —”
Source: SEC Filing (0001628280-26-010185) ↗
Reported in Form 10-K MD&A ('Components of % Change' table).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total U.S. — Annual Volume Growth (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.9% | +1.2 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2024 | Dec 31, 2024 | 3.7% | +19.6 pts | SEC Filing (0001628280-26-010185) ↗ |
| FY2023 | Dec 31, 2023 | -15.9% | -25.5 pts | SEC Filing (0001628280-25-007110) ↗ |
| FY2022 | Dec 31, 2022 | 9.6% | -20.1 pts | SEC Filing (0001628280-24-005348) ↗ |
| FY2021 | Dec 31, 2021 | 29.7% | +14.4 pts | SEC Filing (0001628280-23-004026) ↗ |
| FY2020 | Dec 31, 2020 | 15.3% | +9.7 pts | SEC Filing (0001104659-22-025141) ↗ |
| FY2019 | Dec 31, 2019 | 5.6% | +0.4 pts | SEC Filing (0001104659-21-025751) ↗ |
| FY2018 | Dec 31, 2018 | 5.2% | +2.1 pts | SEC Filing (0001104659-20-023904) ↗ |
| FY2017 | Dec 31, 2017 | 3.1% | -3.2 pts | SEC Filing (0001047469-19-000624) ↗ |
| FY2016 | Dec 31, 2016 | 6.3% | +2.6 pts | SEC Filing (0001047469-18-000856) ↗ |
| FY2015 | Dec 31, 2015 | 3.7% | +1.2 pts | SEC Filing (0001047469-17-000744) ↗ |
| FY2014 | Dec 31, 2014 | 2.5% | +2.2 pts | SEC Filing (0001047469-16-010246) ↗ |
| FY2013 | Dec 31, 2013 | 0.3% | +0.4 pts | SEC Filing (0001047469-15-001377) ↗ |
| FY2012 | Dec 31, 2012 | -0.1% | – | SEC Filing (0001047469-14-001176) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories Total U.S. — Annual Volume Growth (%), annual FY2012–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/tot-vol-us
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.